Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Base to Base biotech podcast 26: Stand Up To Cancer Day
Servier acquires potential treatment for Fragile X syndrome
Novel drug target from Barth syndrome study
Positive phenylketonuria results announced
Lilly hopes $1bn platform leads to new medicines
“Turning point in how we treat EGFR-mutated lung cancer”
Positive results from chronic gout trial
Pfizer and BioNTech say robust immune response with COVID-19 vaccine